外泌体诊断和治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00005514
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 149
Buy Now

2019年外泌体诊断和治疗市场价值为4163.3万美元,预计2020年至2027年复合年增长率为32.2%,到2027年将达到3.5891亿美元。

外泌体是构成蛋白质、DNA 和 RNA 的纳米囊泡。外泌体在诊断癌症时帮助细胞间通讯发挥重要作用。它通过刺激活化的细胞毒性 T 细胞的程序性细胞死亡来降低人体的免疫功能,从而改变人体内肿瘤的进展。由于比传统诊断和治疗方法具有更高的精度和优势,外泌体诊断和治疗市场预计将出现巨大增长。然而,基础设施薄弱和缺乏分离外泌体所需的专业知识可能会阻碍市场增长。

 

外泌体诊断和治疗市场的利润丰厚的区域


市场洞察

比传统诊断和治疗方法更高的精度和优势

外泌体是微小膜囊泡的独特群体,由大多数细胞释放到细胞外空间,最终在体液循环中积累。通过充当细胞信使,它们通过在不同细胞类型之间传输信息来在重要的生理功能中发挥作用。这些微小颗粒将细胞核酸和蛋白质从宿主细胞携带到靶细胞,代表了宿主细胞病理生理状况的综合信息。例如,肿瘤细胞释放的外泌体含有肿瘤特异性 RNA,可以在癌症诊断过程中检测到。这些载体外泌体还可以用作诊断神经退行性和代谢性疾病以及传染病和其他疾病的生物标志物。此外,唾液和尿液等体液中外泌体的存在可能会排除涉及收集侵入性体液的传统方法。因此,对临床无创诊断的日益重视可能会推动基于外泌体的诊断的采用

基于应用的见解

根据应用,外泌体诊断和治疗治疗市场进一步细分为诊断应用和治疗应用。由于人们对外泌体所提供的程序结果的认识不断提高,诊断应用领域在 2019 年占据了更大的市场份额。例如,2016 年 3 月,Sysmex 和 JVCKENWOOD 启动了一项联合计划,开发用于测量外泌体的诊断仪器。此外,预计诊断领域在预测期内的市场复合年增长率将更高。除此之外,外泌体由于其在疾病延长中的作用而成为有前景的治疗平台。外泌体的这种参与可以让我们在靶向药物治疗的帮助下抑制疾病进展。

全球外泌体诊断和治疗市场,按应用划分– 2019年& 2027


基于产品的见解

按产品划分,外泌体诊断和治疗市场是细分的细分为仪器、试剂和软件。2019年,由于越来越多地采用诊断应用仪器,仪器部分在全球外泌体诊断和治疗市场中占据最大份额。然而,预计软件领域在预测期内的复合年增长率最高。这可以归因于对为外泌体诊断和治疗应用中收集的数据提供数据完整性、访问性和安全性的技术平台的需求。

基于最终用户的见解

外泌体诊断和治疗市场按最终用户进一步细分为癌症研究所、医院、诊断中心等。由于癌症病例的增加和对先进诊断方法的需求,癌症研究所细分市场在 2019 年占据了最大的市场份额。癌症研究所专门致力于癌症研究、药物开发和癌症管理研究。外泌体在癌症诊断中的效率预计将在预测期内推动癌症研究所领域的增长。

战略洞察

公司通常采用产品发布和扩张战略来扩大其全球足迹并满足不断增长的需求。这种策略最常被市场参与者采用,以扩大其产品组合。

外泌体诊断和治疗市场的市场参与者采用产品创新策略来满足全球不断变化的客户需求,这也使参与者能够在全球范围内维持其品牌名称。

外泌体诊断和治疗市场 -按应用

  • 诊断
  • 治疗


外泌体诊断和治疗市场 -按产品

  • 仪器
  • 试剂
  • 软件


外泌体诊断和治疗市场&ndash ;按最终用户划分

  • 癌症研究所
  • 医院
  • 诊断中心
  • 其他

外泌体诊断和治疗市场–按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区(APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲 (SAM)
    • 巴西
    • 阿根廷
    • SAM 的其他地区

公司简介

  • Aethlon Medical, Inc
  • Therapeutic Solutions International, Inc
  • ReNeuron Group plc
  • 免疫治疗控股公司
  • 细胞指导系统有限责任公司
  • 生物再生科学
  • Evomic Science LLC
  • NorgenBiotek Corp
  • Exosome Diagnostics, Inc./Bio-Techne
  • MiltenyiBiotec
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is e exosome diagnostic and therapeutic?

Exosome is nanovesicles that constitute proteins, DNA, and RNA. Exosomes play an important role in aiding cell-to-cell communication in the cancer diagnosis. It lowers the body's immune function by stimulating programmed cell death of activated cytotoxic T cells, which modifies neoplasm progression within the human body.

What are the driving factors for the exosome diagnostic and therapeutic market across the globe?

The factors that are driving growth of the market are greater precision and advantages over traditional methods of diagnosis and therapeutics and rise in research and development activities. Moreover, growing preference for noninvasive and novel diagnostic procedures are offering lucrative opportunities for the growth of the market.

Who are the major players in the exosome diagnostic and therapeutic market?

The exosome diagnostic and therapeutic market majorly consists of the players such as Aethlon Medical, Inc., Therapeutic Solutions International, Inc., ReNeuron Group plc, Immune Therapy Holdings AB, Cell Guidance Systems LLC, BioRegenerative Sciences, Evomic Science LLC, Norgen Biotek Corp., Exosome Diagnostics, Inc./Bio-Techne, and Miltenyi Biotec among others.

The List of Companies - Exosome Diagnostic and Treatment Market

  1. Aethlon Medical, Inc
  2. Therapeutic Solutions International, Inc
  3. ReNeuron Group plc
  4. Immune Therapy Holdings AB
  5. Cell Guidance Systems LLC
  6. BioRegenerative Sciences
  7. Evomic Science LLC
  8. Norgen Biotek Corp
  9. Exosome Diagnostics, Inc./Bio-Techne
  10. Miltenyi Biotech

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports